Lilly’s orforglipron and other key catalysts can reshape drug landscape in Q3 2025: GlobalData EP News Bureau Jul 14, 2025 Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…
